Use access key #2 to skip to page content.
$5.61 0.36 (6.86%)
10/13/2008 3:59 PM

Anika Therapeutics, Inc. (ANIK)

CAPS Rating:
*****

The Company develops, manufactures and commercializes therapeutic products for tissue protection, healing and repair.

View Ticker Page (ANIK)

Results 1 - 10 of 27 :   123

Recs

4

Avatar NobodezFool (70.89) Submitted: 12/12/06 12:14 PM : Outperform Start Price: $12.30 ANIK Score: -18.13

PEG .96
Cash Flow
Growth
Positive Earnings Surprises
Am I missing something? Why such little interest in this company? Maybe someone with better analysis skills can explain the lackluster stock performance for me. I see no reason why this should ...

Report this Post Replies: 3 | Reply | Permalink

Recs

2

Avatar suave1007 (< 20) Submitted: 8/14/07 6:54 PM : Outperform Start Price: $16.75 ANIK Score: -29.53

Relatively unknown:"BEST Vanity and Youth Play" thru FDA approved hyloranian acid for orthoritis of knee and removal of aging facial lines. Tripling pdtn facility for future growth. Place limit orders: thin stock.

Report this Post Replies: 0 | Reply | Permalink

Recs

2

Avatar SteadySaber (71.57) Submitted: 6/08/07 5:04 PM : Outperform Start Price: $15.45 ANIK Score: -23.29

New products second half. P/E looks high. Any room to make some money?





This year's earnings trade at a 29 p/e for .51 est. With a ttm p/e of 36. So lets say they hit the numbers and get .51. That should imply an $18 stock bas...

Report this Post Replies: 1 | Reply | Permalink

Recs

1

Avatar luke44 (82.34) Submitted: 7/18/07 7:36 PM : Outperform Start Price: $16.50 ANIK Score: -23.96

he Company develops, manufactures and commercializes therapeutic products for tissue protection and healing

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar 5STARsmallCAPS (< 20) Submitted: 11/24/06 1:02 PM : Outperform Start Price: $11.87 ANIK Score: -17.10

5-star $126 million market cap on 11/24/06
Products for tissue healing and protection, including OrthoVisc.
5STARsmallCAPS picks five star stocks with the smallest market caps.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar bridgeboy0 (30.92) Submitted: 11/09/07 1:34 PM : Outperform Start Price: $13.60 ANIK Score: -20.30

From Motley Fool hard to meet screen.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar salvatore85 (< 20) Submitted: 2/01/07 9:16 PM : Outperform Start Price: $13.31 ANIK Score: -20.00

The high yield, and the low P/E ratio compared to its competitors. The past company performance and its good PEG ratio.

Report this Post Replies: 0 | Reply | Permalink

Recs

1

Avatar RandomGuy123 (64.27) Submitted: 2/08/07 7:39 AM : Outperform Start Price: $13.17 ANIK Score: -19.53

Check out Wall Street Mayhem for the pitch. This company looks great, and recently the FDA approved their cheaper version of Botox.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar electrius (44.08) Submitted: 10/06/07 4:42 PM : Outperform Start Price: $20.59 ANIK Score: -30.64

Elevess and host of future related products, marketed by Galderma will provide growth for multiple years. Already profitable and no debt.

Report this Post Replies: 0 | Reply | Permalink

Recs

0

Avatar zzlangerhans (99.10) Submitted: 1/09/08 8:17 PM : Outperform Start Price: $13.06 ANIK Score: -21.44

Anika has a very low market cap given the number and variety of products it is already marketing. Quarterly revenues have substantial potential for growth given planned launch of Monovisc in Europe this quarter and possible new marketing deal for Ele...

Report this Post Replies: 0 | Reply | Permalink

Featured Broker Partners